* Botanix is reviewing multiple commercialisation strategies and will elect the option that delivers the highest shareholder value for the investment
* Potential for accelerated advancement of this product could be developed and marketed without FDA approval.
* Permetrex enabled forumulation has competitive advantages over incumbent brands, of which many contain alcohol and preservatives that can actively dry out the skin and/or cause allergic reactions.
* Botanix is working with multiple parties to test application of Permetrex techonology to solve problems that have arisen in clinical studies.
Absolute game changer folks.
BOT Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)